Cipla partners with CSIR-CDRI to develop formulation for fungal keratitis
Drug major Cipla on Thursday said it has tied up with CSIR-Central Drug Research Institute to jointly develop a novel ...
Drug major Cipla on Thursday said it has tied up with CSIR-Central Drug Research Institute to jointly develop a novel ...
Mumbai: Drug major Cipla is eyeing acquisitions and inorganic partnerships in the US market while consolidating its presence across segments ...
Drug major Cipla is eyeing acquisitions and inorganic partnerships in the US market while consolidating its presence across segments in ...
Samina Hamied, executive vice-chairperson of Cipla who represents the promoter family on Thursday said she will be stepping down from ...
MUMBAI: Cipla said it expects to end FY24 with the earnings before interest, tax, depreciation and ammortisation (Ebitda) margins of ...
Drug major Cipla on Thursday said Samina Hamied has decided to step down from the position of Executive Vice Chairperson ...
Asia-Pacific markets edged higher on Monday after China left its benchmark lending rates unchanged. Hang Seng and Kospi ...
Bengaluru: Cipla, India's third-largest generic drugmaker by sales, posted a bigger-than-expected rise in second-quarter profit on Friday, boosted by strength ...
Torrent Pharma’s bid to acquire the stake of the promoter, the Hamied family, in Cipla has stalled over valuation differences, ...
Torrent Pharma on Monday called the reports about the drug maker in the race to acquire the promoters' stake in ...
Copyright © 2021 Asia Post.
Asia Post is not responsible for the content of external sites.